Molecular mechanisms of cellular gene expression reprogramming by HIV Tat protein
HIV Tat蛋白重编程细胞基因表达的分子机制
基本信息
- 批准号:7321652
- 负责人:
- 金额:$ 39.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-12-01 至 2009-11-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdenovirusesAffectAllelesAntigen-Presenting CellsApplications GrantsBinding SitesCellsConditionDNADendritic CellsElongation FactorGene ExpressionGenesGenomeGoalsHIVHIV InfectionsHIV tat ProteinHIV-1HumanImmuneInfectionLaboratoriesLibrariesLocationMapsMediatingModificationMolecularMutateNeuronsPathogenesisPhenotypePhysiologyPlayPoint MutationProductionRNARNA BindingRNA SequencesRegulationRetroviral VectorRoleSTAT1 geneSiteT-LymphocyteTarsTestingTrans-ActivatorsTranscriptViralViruscell typecyclin T1designdomain mappingexpression vectorimprovedinsightmacrophagemutantpathogen exposureprogramsresearch studytat Proteintranscription factor
项目摘要
DESCRIPTION (provided by applicant): The goal of this proposal is to gain insights into how HIV-1 Tat mediates its effects on host cell gene expression. Tat is among the first genes expressed during HIV-1 infection and is essential for viral gene expression and virus production. Tat increases HIV-1 gene expression by functioning as an elongation factor and interacting with TAR, a RNA sequence present at the beginning of the HIV viral transcripts, and with the host cell factors CDK9 and cyclin T1. The interaction of Tat with these and other host cell transcriptional regulators might be expected to affect host cell gene expression. Indeed, there is considerable evidence that Tat can affect the physiology of T lymphocytes, neurons and antigen presenting cells. Recent studies from our laboratory have shown that the gene expression programs of dendritic cells and macrophages are modified by pathogen exposure and that these modifications can provide important clues to pathogenesis. We have shown that dendritic cell reprogramming by HIV-1 can create conditions that favor virus spread, and that the effect is mediated by the HIV-1 transactivator Tat. This proposal is designed to improve our understanding of the means by which Tat expression causes changes in host cell gene expression in immune cells targeted by HIV-1. To accomplish this, the specific aims of the proposal are 1) To develop a library of adenovirus and retroviral vectors expressing multiple wild type and mutated Tat proteins. 2) To determine the effects of two wild type alleles of Tat on host cell gene expression in immune cells targeted by HIV-1 infection. 3) To map the domain of Tat that is responsible for modifying the host cell gene expression program. 4) To investigate the genome-scale location of the transcription factors STAT1 and IRF7 during Tat expression, as these factors are upregulated by HIV-1 infection and Tat expression. 5) To investigate the mechanism by which Tat reprograms host cell gene expression using genome-scale location analysis experiments designed to detect DNA and RNA binding.
描述(由申请人提供):本提案的目标是深入了解HIV-1达特如何介导其对宿主细胞基因表达的影响。达特是HIV-1感染过程中最先表达的基因之一,对病毒基因表达和病毒产生至关重要。达特通过作为延伸因子并与TAR(HIV病毒转录物起始处存在的RNA序列)以及宿主细胞因子CDK 9和细胞周期蛋白T1相互作用来增加HIV-1基因表达。达特与这些和其他宿主细胞转录调节因子的相互作用可能会影响宿主细胞基因表达。事实上,有相当多的证据表明,达特可以影响T淋巴细胞,神经元和抗原呈递细胞的生理学。我们实验室最近的研究表明,树突状细胞和巨噬细胞的基因表达程序被病原体暴露所修饰,这些修饰可以为发病机制提供重要线索。我们已经证明,HIV-1对树突状细胞的重编程可以创造有利于病毒传播的条件,并且这种作用是由HIV-1反式激活因子达特介导的。该建议旨在提高我们对达特表达引起HIV-1靶向免疫细胞中宿主细胞基因表达变化的方式的理解。为了实现这一点,该提议的具体目标是1)开发表达多种野生型和突变的达特蛋白的腺病毒和逆转录病毒载体的文库。2)确定达特的两个野生型等位基因对HIV-1感染靶向免疫细胞中宿主细胞基因表达的影响。3)定位负责修饰宿主细胞基因表达程序的达特结构域。4)研究转录因子STAT 1和IRF 7在达特表达过程中的基因组规模定位,因为这些因子被HIV-1感染和达特表达上调。5)研究达特通过基因组规模的定位分析实验检测DNA和RNA结合来重编程宿主细胞基因表达的机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANNA ALDOVINI其他文献
ANNA ALDOVINI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANNA ALDOVINI', 18)}}的其他基金
Prophylactic oral vaccination for SIV and SHIV infections and AIDS prevention
针对 SIV 和 SHIV 感染以及艾滋病预防的预防性口服疫苗接种
- 批准号:
9322435 - 财政年份:2016
- 资助金额:
$ 39.3万 - 项目类别:
Role of p38 MAPK activation in AIDS pathogenesis
p38 MAPK 激活在 AIDS 发病机制中的作用
- 批准号:
8811918 - 财政年份:2014
- 资助金额:
$ 39.3万 - 项目类别:
Role of p38 MAPK activation in AIDS pathogenesis
p38 MAPK 激活在 AIDS 发病机制中的作用
- 批准号:
9235219 - 财政年份:2014
- 资助金额:
$ 39.3万 - 项目类别:
Role of p38 MAPK activation in AIDS pathogenesis
p38 MAPK 激活在 AIDS 发病机制中的作用
- 批准号:
8731523 - 财政年份:2014
- 资助金额:
$ 39.3万 - 项目类别:
In vivo suppression of SIV-mediated immune activation
体内抑制 SIV 介导的免疫激活
- 批准号:
8603383 - 财政年份:2013
- 资助金额:
$ 39.3万 - 项目类别:
In vivo suppression of SIV-mediated immune activation
体内抑制 SIV 介导的免疫激活
- 批准号:
8717584 - 财政年份:2013
- 资助金额:
$ 39.3万 - 项目类别:
Pathways of HIV neurodegeneration and dimethyl fumarate (DMF/MMF) neuroprotection
HIV 神经变性和富马酸二甲酯 (DMF/MMF) 神经保护的途径
- 批准号:
8472538 - 财政年份:2011
- 资助金额:
$ 39.3万 - 项目类别:
Pathways of HIV neurodegeneration and dimethyl fumarate (DMF/MMF) neuroprotection
HIV 神经变性和富马酸二甲酯 (DMF/MMF) 神经保护的途径
- 批准号:
8669822 - 财政年份:2011
- 资助金额:
$ 39.3万 - 项目类别:
Pathways of HIV neurodegeneration and dimethyl fumarate (DMF/MMF) neuroprotection
HIV 神经变性和富马酸二甲酯 (DMF/MMF) 神经保护的途径
- 批准号:
8368087 - 财政年份:2011
- 资助金额:
$ 39.3万 - 项目类别:
Pathways of HIV neurodegeneration and dimethyl fumarate (DMF/MMF) neuroprotection
HIV 神经变性和富马酸二甲酯 (DMF/MMF) 神经保护的途径
- 批准号:
8210631 - 财政年份:2011
- 资助金额:
$ 39.3万 - 项目类别:
相似海外基金
cGAS-STING Pathway Targeting Replicative Adenoviruses with CD46 Tropism and AFP Promoter Conditional Replication Restriction for the Treatment of Hepatocellular Carcinoma
cGAS-STING 通路靶向具有 CD46 趋向性和 AFP 启动子的复制腺病毒条件性复制限制用于治疗肝细胞癌
- 批准号:
10436626 - 财政年份:2021
- 资助金额:
$ 39.3万 - 项目类别:
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
- 批准号:
10557162 - 财政年份:2021
- 资助金额:
$ 39.3万 - 项目类别:
Molecular therapy of replication-competent adenoviruses targeting characteristic gene mutations found in mesothelioma
针对间皮瘤中发现的特征基因突变的具有复制能力的腺病毒的分子疗法
- 批准号:
21K08199 - 财政年份:2021
- 资助金额:
$ 39.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
- 批准号:
10330464 - 财政年份:2021
- 资助金额:
$ 39.3万 - 项目类别:
Structural characterization of nucleoprotein cores of human adenoviruses
人腺病毒核蛋白核心的结构表征
- 批准号:
9807741 - 财政年份:2019
- 资助金额:
$ 39.3万 - 项目类别:
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
- 批准号:
41625-2013 - 财政年份:2018
- 资助金额:
$ 39.3万 - 项目类别:
Discovery Grants Program - Individual
The therapeutic strategies with augmented replications of oncolytic adenoviruses for malignant mesothelioma
溶瘤腺病毒增强复制治疗恶性间皮瘤的治疗策略
- 批准号:
18K15937 - 财政年份:2018
- 资助金额:
$ 39.3万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
- 批准号:
41625-2013 - 财政年份:2017
- 资助金额:
$ 39.3万 - 项目类别:
Discovery Grants Program - Individual
Exploring the effects of nutrient deprivation on T cells and oncolytic adenoviruses, in order to create immune activators for tumour therapy
探索营养剥夺对 T 细胞和溶瘤腺病毒的影响,以创造用于肿瘤治疗的免疫激活剂
- 批准号:
1813152 - 财政年份:2016
- 资助金额:
$ 39.3万 - 项目类别:
Studentship
Research on detection of novel adenoviruses by genetic methods
新型腺病毒的基因检测研究
- 批准号:
16K09118 - 财政年份:2016
- 资助金额:
$ 39.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)